Publication | Open Access
A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic cough
22
Citations
31
References
2022
Year
Lesogaberan improved cough hypersensitivity and the number of bouts of coughing, but not coughs per hour. This implies a possible role for peripheral GABA<sub>B</sub> receptors in refractory chronic cough.
| Year | Citations | |
|---|---|---|
Page 1
Page 1